By Professor Monica M. Lahra

Book Chapters

George CRR; Jeffery HE; Lahra MM, 2022, 'Infection of mother and baby', in Keeling S Fetal and Neonatal Pathology, pp. 207 - 245, http://dx.doi.org/10.1007/978-3-030-84168-3_9

George CRR; Smith HV; Lahra MM, 2022, 'Neisseria meningitidis', in Molecular Typing in Bacterial Infections Volume I Second Edition, pp. 85 - 99, http://dx.doi.org/10.1007/978-3-030-74018-4_3

George CRR; Lahra MM; Jeffery HE, 2018, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Keeling S Fetal and Neonatal Pathology Fifth Edition, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9

Goire N; Speers DJ; Lahra MM; Whiley DM, 2015, 'Neisseria gonorrhoeae: The Pathogen, Diagnosis, and Antimicrobial Resistance', in Singh SK (ed.), Human Emerging and Re Emerging Infections Viral and Parasitic Infections Volume 2, pp. 683 - 697, http://dx.doi.org/10.1002/9781118644843.ch37

George CRR; Lahra MM; Jeffery HE, 2015, 'The impact of infection during pregnancy on the mother and baby', in Keeling S Fetal and Neonatal Pathology, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9

Jeffery HE; Lahra MM, 2007, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Fetal and Neonatal Pathology, Springer Nature, pp. 379 - 423, http://dx.doi.org/10.1007/978-1-84628-743-5_16

Journal articles

Hurley S; Lahra MM; Applegate TL; van Hal S, 2026, 'Atypical infections caused by pathogenic Neisseria species N. meningitidis and N. gonorrhoeae.', Clinical Microbiology Reviews, pp. e0009126, http://dx.doi.org/10.1128/cmr.00091-26

Lahra M; He S; Hogan T, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2026', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.055

Johnston N; Kuang JSJ; Lee R; Malik R; Rajkumar A; Lahra M; Johnson AM; Williams PCM, 2026, 'A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings', Pediatric Infectious Disease Journal, 45, http://dx.doi.org/10.1097/INF.0000000000005280

Seib KL; Donovan B; Jin F; Thng C; Yeung B; Comninos N; Bopage RI; Ray A; Mahony A; Chow EPF; Chen MY; Maddaford K; Lau H; Westall P; Lu D; Bavinton BR; Petoumenos K; Whiley DM; Jennings MP; Jennison AV; Kaldor J; Guy R; Lahra MM; Costello J; Mackie B; Templeton DJ; Eu B; O'Reilly M; Fairley CK; McNulty A; Varma R; Lewis DA; Grulich AE, 2026, 'Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection', New England Journal of Medicine, 395, pp. 349 - 361, http://dx.doi.org/10.1056/NEJMoa2516739

Maskell J; O'Connor M; Lahra MM; Whiley DM; van Hal S; Pryce TM, 2026, 'False-positive Neisseria gonorrhoeae results on the Abbott Alinity m STI assay caused by Neisseria meningitidis: two cases from Australia', Journal of Clinical Microbiology, 64, http://dx.doi.org/10.1128/jcm.00347-26

van Hal SJ; Goeman E; Davidson Y; Jenkins F; Whiley D; Lahra M, 2026, 'Neisseria meningitidis MenY ST-1466 harbouring Neisseria gonorrhoeae 16S rRNA allele causing false-positive Aptima® gonococcal nucleic acid amplification test results', Clinical Microbiology and Infection, 32, pp. 1187 - 1189, http://dx.doi.org/10.1016/j.cmi.2026.01.027

Lahra M; Hurley S; Van Hal S; Hogan T, 2026, 'Australian Gonococcal Surveillance Program, 1 October to 31 December 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.035

Lahra M; Hurley S; Hogan T, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.027

Lahra M; Hurley S; Hogan T, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.036

Walker LJ; van Hal SJ; Li C; Nigro SJ; Donnan E; Ryder N; Lahra MM; Amin J, 2026, 'Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022–2024', Emerging Infectious Diseases, 32, pp. 905 - 913, http://dx.doi.org/10.3201/eid3206.251399

van Hal SJ; Fifer H; Lahra MM, 2026, 'Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance', Emerging Infectious Diseases, 32, pp. 839 - 843, http://dx.doi.org/10.3201/eid3206.260378

Lahra M; Hurley S; Van Hal S; Hogan T, 2026, 'Australian Gonococcal Surveillance Program, 1 July to 30 September 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.018

Brell N; Story C; Van Hal S; Weber M; Lahra M, 2026, 'Maternal vaginal colonisation with Neisseria meningitidis serogroup B and late onset neonatal invasive meningococcal disease', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.017

Wong A; Applegate T; Mahony A; Xu G; Houghton R; Hogan T; Lahra M, 2026, 'Transport time, not transport method, predicts Neisseria gonorrhoeae culture yield in an urban setting', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.011

Lahra M; Hurley S; Van Hal S; Hogan T, 2026, 'Australian Gonococcal Surveillance Program, 1 April to 30 June 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.005

Lahra M; Hogan T, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.006

van Hal SJ; Jenkins F; Hogan TR; Ray S; Kundu RL; Marshall HS; Bowden R; Lahra MM, 2026, 'Gene exchange between Neisseria meningitidis and Neisseria gonorrhoeae', Microbial Genomics, 12, http://dx.doi.org/10.1099/mgen.0.001623

Harant A; Zanuzdana A; Tomczyk S; Eckmanns T; Kong I; Lahra M; Gill S; Hendriksen R; Perovic O; Corso A; Behrendtz SL; Kreienbrock L; Alshamrani M; Harbarth S; De Kraker M; Ekelund O; Karatuna O; Ruesen C; Bertagnolio S; Hutin Y, 2026, 'Surveillance of antimicrobial resistance by a global network of WHO collaborating centres', Bulletin of the World Health Organization, 104, pp. 259 - 273, http://dx.doi.org/10.2471/BLT.25.294384

Marshall H; Ward J; Seib K; Richmond P; Lahra M; Wang B; Kahler C; van Hal S; Ong J; McMillan M; Maiden M; Ladhani S; Vlaev I; Flood L; Lambert S; Crawford N; Quick K; Karnon J, 2026, 'Centre-of-Research-Excellence in Neisseria Disease Control (NEIS CRE): Long-term 4CMenB effectiveness against Neisseria', Australian and New Zealand Journal of Public Health, 50, pp. 100432, http://dx.doi.org/10.1016/j.anzjph.2026.100432

Whiley D; Van Hal S; Pryce T; Lahra M, 2025, '2025 Review of Public Health Laboratory Network Australia Neisseria gonorrhoeae National Nucleic Acid Amplification Testing Guidelines', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.067

Lahra M; Hurley S; Van Hal S; Hogan T, 2025, 'Australian Gonococcal Surveillance Programme Annual Report, 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.056

Lahra M; Hurley S; George CRR; Van Hal S; Hogan T, 2025, 'Australian Meningococcal Surveillance Programme Annual Report, 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.057

van Hal SJ; Lahra MM; Whiley DM, 2025, 'Determining targets for ceftriaxone resistance detection in Neisseria gonorrhoeae based on genotype–phenotype data: an observational study', Lancet Microbe, 6, http://dx.doi.org/10.1016/j.lanmic.2025.101199

George CRR; Varadhan H; Naqvi S; Locker B; Howes M; van Hal S; Lahra MM, 2025, 'Invasive Urogenital Neisseria meningitidis Serogroup Y Multilocus Sequence Type 1466', Emerging Infectious Diseases, 31, pp. 2067, http://dx.doi.org/10.3201/eid3110.250902

Lan PT; Nguyen TTP; Anh VT; Golparian D; Van NTT; Maatouk I; Unemo M; Doanh LH; Hoa PQ; Hoa PD; Phuong PTM; Trang TM; Van TTD; Nam PT; Vinh NTH; Giang QTH; Tung VT; Tuan ND; Thuy HP; Lam THT; Pham NTU; Van Loi Doan E; Vo PTD; Nguyen TD; Nguyen PTT; Le KT; Bui TM; Pham NN; Duong BH; Dang ADQ; Hoang TMK; Nguyen QTN; Nguyen HT; Nguyen TTK; An NH; Van Dung T; Binh NT; Khoa NT; Lahra MM; Wi T; Unemo M; Jacobsson S; Schröder D, 2025, 'The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024', Lancet Regional Health Western Pacific, 63, http://dx.doi.org/10.1016/j.lanwpc.2025.101709

Unemo M; Lahra MM; Cole MJ; Marcano Zamora D; Jacobsson S; Galarza P; Martin I; Kreisel KM; Galas M; Bertagnolio S; Ramon-Pardo P; Maatouk I; Wi T, 2025, 'WHO global gonococcal antimicrobial surveillance programmes, 2019–22: a retrospective observational study', Lancet Microbe, 6, http://dx.doi.org/10.1016/j.lanmic.2025.101181

Maatouk I; Vumbugwa P; Cherdtrakulkiat T; Heng LS; Hoffman I; Palaypayon N; Kakooza F; Kittiyaowamarn R; Kyambadde P; Lahra MM; Lan PT; Maseko V; Matoga M; Machiha A; Müller E; Nguyen TTP; Doanh LH; Ouk V; Setiawaty V; Sia SB; Hartono TS; Virak M; Thuy Van NT; Unemo M; Wi T, 2025, 'Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study', Lancet Regional Health Western Pacific, 61, http://dx.doi.org/10.1016/j.lanwpc.2025.101663

Lahra MM; Van Hal S; Hogan TR, 2025, 'Australian Gonococcal Surveillance Program, 1 October to 31 December 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.036

Lahra MM; Hogan TR, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2025', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.045

Lahra MM; Hogan TR, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.039

Lahra MM; van Hal S; Hogan TR, 2025, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.018

Lahra MM; van Hal S; Hogan TR, 2025, 'Australian Gonococcal Surveillance Programme Annual Report, 2023', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.007

Lahra MM; Hogan TR, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.017

Lahra M; Van Hal S; Hogan T, 2025, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2025', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.046

Lahra MM; van Hal S; Hutabarat SN; Hogan TR, 2025, 'Australian Gonococcal Surveillance Program, 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.002

Lahra MM; van Hal S; Hutabarat SN; Hogan TR, 2025, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.001

Lahra MM; Hutabarat SN; van Hal S; Hogan TR, 2025, 'Erratum: Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.008

van Hal SJ; Le T; Jenkins F; Kundu RL; Limnios EA; McNamara LA; Sharma S; Kersh EN; Lahra MM, 2025, 'Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections', Emerging Infectious Diseases, 31, pp. 86 - 93, http://dx.doi.org/10.3201/eid3101.240940

Williams PCM; Mostaghim M; Harrison J; Lahra M; Greenhalgh M; O’Sullivan M; Maley M; Oei J-L; Koirala A; Popat H; Lui K; McMullan B; Palasanthiran P; Kesson A; Isaacs D; Bartlett AW, 2025, 'Epidemiology of early-onset and late-onset invasive infections in Australian neonates and infants: a retrospective multicentre study', BMJ Public Health, 3, pp. e002733, http://dx.doi.org/10.1136/bmjph-2025-002733

Lahra MM; George CRR; van Hal S; Hogan TR, 2024, 'Australian Meningococcal Surveillance Programme Annual Report, 2023', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.52

Lahra MM; Hutabarat SN; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.54

Lahra MM; Hutabarat SN; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2024', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.53

Bertagnolio S; Dobreva Z; Centner CM; Olaru ID; Donà D; Burzo S; Huttner BD; Chaillon A; Gebreselassie N; Wi T; Hasso-Agopsowicz M; Allegranzi B; Sati H; Ivanovska V; Kothari KU; Balkhy HH; Cassini A; Hamers RL; Weezenbeek KV; Aanensen D; Alanio A; Alastruey-Izquierdo A; Alemayehu T; Al-Hasan M; Allegaert K; Al-Maani AS; Al-Salman J; Alshukairi AN; Amir A; Applegate T; Araj GF; Villalobos MA; Årdal C; Ashiru-Oredope D; Ashley EA; Babin FX; Bachmann LH; Bachmann T; Baker KS; Balasegaram M; Bamford C; Baquero F; Barcelona LI; Bassat Q; Bassetti M; Basu S; Beardsley J; Vásquez GB; Berkley JA; Bhatnagar AK; Bielicki J; Bines J; Bongomin F; Bonomo RA; Bradley JS; Bradshaw C; Brett A; Brink A; Brown C; Brown J; Buising K; Carson C; Carvalho AC; Castagnola E; Cavaleri M; Cecchini M; Chabala C; Chaisson RE; Chakrabarti A; Chandler C; Chandy SJ; Charani E; Chen L; Chiara F; Chowdhary A; Chua A; Chuki P; Chun DR; Churchyard G; Cirillo D; Clack L; Coffin SE; Cohn J; Cole M; Conly J; Cooper B; Corso A; Cosgrove SE; Cox H; Daley CL; Darboe S; Darton T; Davies G; de Egea V; Dedeić-Ljubović A; Deeves M; Denkinger C; Dillon JAR; Dramowski A; Eley B, 2024, 'WHO global research priorities for antimicrobial resistance in human health', Lancet Microbe, 5, http://dx.doi.org/10.1016/S2666-5247(24)00134-4

van Hal SJ; Sherry N; Coombs G; Mowlaboccus S; Whiley DM; Lahra MM, 2024, 'Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone', Lancet Infectious Diseases, 24, pp. e547 - e548, http://dx.doi.org/10.1016/S1473-3099(24)00486-9

Back to profile page